Author: Raj Gaurav Rai

Raj Gaurav Rai is the founder and chief editor of EarnFree.in with 10+ years of experience in Indian equity markets, technical analysis, Nifty 50, Bank Nifty F&O trading, cryptocurrency and financial journalism. He actively trades NSE/BSE equities and crypto markets, ensuring all analysis is grounded in real market experience. Based in Varanasi, Uttar Pradesh, India.

Gold purchases (in metric tons) by global CBs. The last 3.5 years of purchases are well above the 14 year average – BBG Intelligence dataCiti doesn’t rule out gold at $3000 over the next 12-18 mo ———- China, Russia and Turkey will continue to increase gold’s share of reserves. It is more volatile than US government bonds, but it is liquid. It is one of the few assets that are outside the financial system – former chief investment strategist at Bridgewater AssociatesGold demand is on track to break records thanks to active central bank buying, which has continued and will continue this year – World Gold Council (WGC) predicts

Gold purchases (in metric tons) by global CBs. The last 3.5 years of purchases are well above the 14 year average – BBG Intelligence data […]

Shares To watch

Cello World: Initiating Coverage with an UPSIDE of 15% | One up on houseware street; We estimate 15%/18%/17% revenue/EBITDA/PAT CAGRs over FY2024-27E Muthoot Finance: ADD […]

Aurobindo Pharma | USFDA Approval– Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market their version of Mometasone Furoate Monohydrate Nasal Spray, which is equivalent to Nasonex Nasal Spray. – This new product will be launched in the first quarter of fiscal year 2025, potentially opening up new revenue streams for the company

Aurobindo Pharma | USFDA Approval – Aurobindo Pharma Limited has received final approval from the USFDA to manufacture and market their version of Mometasone Furoate […]